BAZ2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.225000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.201600E-01
Normal-vs-Stage2
3.682600E-01
Normal-vs-Stage3
1.285150E-01
Normal-vs-Stage4
5.083600E-01
Stage1-vs-Stage2
2.759600E-01
Stage1-vs-Stage3
2.047700E-02
Stage1-vs-Stage4
3.326400E-01
Stage2-vs-Stage3
6.479700E-02
Stage2-vs-Stage4
9.493800E-01
Stage3-vs-Stage4
6.698400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.590000E-01
Normal-vs-AfricanAmerican
2.592800E-01
Normal-vs-Asian
4.221800E-01
Caucasian-vs-AfricanAmerican
3.878800E-01
Caucasian-vs-Asian
3.772800E-01
AfricanAmerican-vs-Asian
8.982000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.354800E-01
Normal-vs-Female
3.084400E-01
Male-vs-Female
2.370400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.830200E-01
Normal-vs-Age(41-60Yrs)
8.165400E-01
Normal-vs-Age(61-80Yrs)
2.772000E-01
Normal-vs-Age(81-100Yrs)
2.924400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.841800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.566200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.523000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.022100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.969700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.602400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.312200E-01
Normal-vs-Daily Drinker
3.271800E-01
Normal-vs-Weekly Drinker
2.099000E-01
Normal-vs-Occasional Drinker
9.519800E-01
Normal-vs-Social Drinker
5.996000E-01
Non Drinker-vs-Daily Drinker
5.658600E-01
Non Drinker-vs-Weekly Drinker
5.710000E-01
Non Drinker-vs-Occasional Drinker
1.503510E-02
Non Drinker-vs-Social Drinker
2.818000E-01
Daily Drinker-vs-Weekly Drinker
3.100800E-01
Daily Drinker-vs-Occasional Drinker
5.716100E-02
Daily Drinker-vs-Social Drinker
5.512600E-01
Weekly Drinker-vs-Occasional Drinker
2.007600E-02
Weekly Drinker-vs-Social Drinker
1.928570E-01
Occasional Drinker-vs-Social Drinker
2.778000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.351700E-02
Normal-vs-Grade 2
5.798200E-03
Normal-vs-Grade 3
2.183100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.894800E-01
Grade 1-vs-Grade 3
7.990800E-01
Grade 1-vs-Grade 4
7.351700E-02
Grade 2-vs-Grade 3
8.450100E-02
Grade 2-vs-Grade 4
5.798200E-03
Grade 3-vs-Grade 4
2.183100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.881640E-01
Normal-vs-NonDiabetic
5.034000E-01
Diabetic-vs-NonDiabetic
1.485980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.265600E-01
Normal-vs-NoPancreatitis
4.121600E-01
Pancreatitis-vs-NoPancreatitis
8.138000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.866200E-01
Normal-vs-N1
3.555400E-01
N0-vs-N1
8.361000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.307200E-01
Normal-vs-TP53-NonMutant
6.767200E-01
TP53-Mutant-vs-TP53-NonMutant
3.842200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
